Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-25

FDA Approved: ARAKODA — Supplemental Application (60 Degrees Pharmaceuticals, INC.)

View source ↗

Summary

The FDA approved a supplemental application for ARAKODA (tafenoquine) by 60 Degrees Pharmaceuticals, expanding the medication’s labeling/indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arakoda (tafenoquine)

Snippet

SUPPL AP for ARAKODA (TAFENOQUINE)